Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:FLKS Flex Pharma (FLKS) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisCompetitorsTrends About Flex Pharma Stock (NASDAQ:FLKS) 30 days 90 days 365 days Advanced Chart Ad Behind the MarketsElon Musk: my AI will be “worth more than Tesla”Tesla made Elon Musk the richest man in human history. And now, Elon's got a new AI project...Get all the details here >>> Get Flex Pharma alerts:Sign Up Key Stats Today's Range$1.70▼$1.7850-Day Range$0.57▼$14.5152-Week Range$0.26▼$1.49Volume29,922 shsAverage Volume2.03 million shsMarket Capitalization$30.90 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewFlex Pharma, Inc., a biotechnology company, develops and commercializes products for the treatment of muscle cramps, spasms, and spasticity associated with neurological conditions and exercise-associated muscle cramps in the United States. It operates in two segments, Consumer Operations and Drug Development. The company's lead drug candidate is FLX-787, a single molecule, chemically synthesized, and dual transient receptor potential V1/A1 ion channel activator, which completed an exploratory Phase II clinical trial in Australia for the treatment of patients with multiple sclerosis. It also offers HOTSHOT, a consumer beverage to prevent and treat exercise associated muscle cramps. The company markets and sells its HOTSHOT products online through its direct-to-consumer Website and through third-party Websites, including a retailer that offers international shipping. Flex Pharma, Inc. was founded in 2014 and is headquartered in Boston, Massachusetts.Read More… Receive FLKS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Flex Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address FLKS Stock News HeadlinesFLEX LNG: A Bond-Like 11.9% Yield To Lock Before Rate CutsSeptember 9, 2024 | seekingalpha.comFLEX LNG Ltd. (FLNG) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | seekingalpha.comElon Musk: my AI will be “worth more than Tesla”Tesla made Elon Musk the richest man in human history. And now, Elon's got a new AI project...January 8, 2025 | Behind the Markets (Ad)Construction Partners, Inc. (ROAD) Q3 2024 Earnings Call TranscriptAugust 9, 2024 | seekingalpha.comWayfair Inc. (W) Q2 2024 Earnings Call TranscriptAugust 3, 2024 | seekingalpha.comQ2 2024 AGCO Corp Earnings CallJuly 31, 2024 | finance.yahoo.comFlex Ltd. (FLEX) Q1 2025 Earnings Call TranscriptJuly 24, 2024 | seekingalpha.comFlex Ltd.: Undervalued With Solid FundamentalsApril 4, 2024 | seekingalpha.comSee More Headlines FLKS Stock Analysis - Frequently Asked Questions How were Flex Pharma's earnings last quarter? Flex Pharma Inc (NASDAQ:FLKS) posted its quarterly earnings results on Wednesday, May, 1st. The biotechnology company reported ($0.12) earnings per share for the quarter. The biotechnology company had revenue of $0.11 million for the quarter. Flex Pharma had a negative trailing twelve-month return on equity of 98.04% and a negative net margin of 1,208.42%. When did Flex Pharma IPO? Flex Pharma (FLKS) raised $60 million in an initial public offering (IPO) on Thursday, January 29th 2015. The company issued 4,600,000 shares at $12.00-$14.00 per share. Jefferies and Piper Jaffray served as the underwriters for the IPO and JMP Securities, Cantor Fitzgerald and Roth Capital Partners were co-managers. What other stocks do shareholders of Flex Pharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that Flex Pharma investors own include Micron Technology (MU), Ocular Therapeutix (OCUL), SCYNEXIS (SCYX), Idera Pharmaceuticals (IDRA), Celldex Therapeutics (CLDX), Gilead Sciences (GILD) and Histogenics (HSGX). Company Calendar Last Earnings5/01/2019Today1/08/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:FLKS CUSIPN/A CIK1615219 Webwww.flex-pharma.com Phone617-874-1821FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-21,920,000.00 Net Margins-1,208.42% Pretax MarginN/A Return on Equity-98.04% Return on Assets-83.37% Debt Debt-to-Equity RatioN/A Current Ratio6.86 Quick Ratio6.74 Sales & Book Value Annual Sales$840,000.00 Price / Sales36.79 Cash FlowN/A Price / Cash FlowN/A Book Value$0.51 per share Price / Book3.35Miscellaneous Outstanding Shares18,070,000Free FloatN/AMarket Cap$30.90 million OptionableNot Optionable Beta1.65 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (NASDAQ:FLKS) was last updated on 1/8/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Flex Pharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Flex Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.